In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
about
In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phasesMelanized fungi in human diseaseSporothrix schenckii and SporotrichosisPharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsScedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungiTriazole Resistance in Aspergillus Species: An Emerging Problem.Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest.Effects of disrupting the polyketide synthase gene WdPKS1 in Wangiella [Exophiala] dermatitidis on melanin production and resistance to killing by antifungal compounds, enzymatic degradation, and extremes in temperature.Susceptibility of filamentous fungi to voriconazole tested by two microdilution methodsVoriconazole: the newest triazole antifungal agentIn vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogensIn vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatumGerminated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole.Antifungal pharmacodynamics: review of the literature and clinical applications.Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosisTesting conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study.Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study.Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi.Antifungal pharmacodynamics: concentration-effect relationships in vitro and in vivo.Cladophialophora bantiana brain abscess in a solid-organ transplant recipient: case report and review of the literature.Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility patternNew developments in chemotherapy for non-invasive fungal infections.Review of the safety and efficacy of voriconazole.High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiencyScedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanideScedosporium species infections and treatments.Infections caused by Fusarium species.Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004.Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.Pharmacokinetics of antifungal agents in children.Therapy of infections caused by dematiaceous fungi.Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazoleIsolation of Exophiala dermatitidis from endotracheal aspirate of a cancer patient.In search of the holy grail of antifungal therapyDematiaceous fungi.
P2860
Q24530443-1941B7D9-BAA6-4457-BE50-EF46D78B2858Q24633163-4618A102-595F-46C1-AA79-D455F84E0805Q24635012-0DCAFA26-FE5F-4247-AB49-8E9904C35707Q27025299-F0861BB8-D560-4A8A-B77A-49B7799B40B8Q28315344-A14915B5-C79C-4071-835F-3B96A1595A85Q28355507-DDC18E86-4CE3-40DE-9E17-21D232F1EC93Q30235566-79CA321B-7D77-4051-8904-2157EA6345E9Q31121317-289111B6-E01A-4F7D-90F9-1B3BBD5D6284Q33247219-DE7AFB9C-EFA2-4F4C-878E-169FDC9BC06DQ33592487-4098E255-8AEC-49EF-B3C3-4862CEB124A9Q33946021-AA0A09FA-DC34-4220-8DF7-41CC23F04716Q33976817-93C92EA6-F5F1-4F81-919C-F0AA6D06FFE2Q33979873-2831D187-D6A6-4B0E-9BE7-B17059BDF2BFQ33981488-A4E10465-C1EA-4712-BC18-574547522B10Q34083129-CBBAB3B1-C5CA-4FB9-8DAC-086917192797Q34092362-F784EC14-C148-46B2-8529-7AA86CF28F14Q34109399-4862C5CA-BF5D-4C7B-A3C5-67E4F2714179Q34195380-7E04DE75-E710-496F-B8B9-22453460AAD3Q34202213-2DFFA802-2120-42D9-A1CB-C4F78FC80A73Q34288185-7E3B1C78-9516-43D6-9E95-D874286DCBE0Q34335230-744A502F-0C96-4D5F-885A-043A9D49656FQ34348018-B9B90BA5-4B6E-410A-BB8B-4400E2C4242AQ34407897-3EFA14ED-BE65-4B04-99DB-25D759F3D203Q34433129-72C95145-D7CC-4A00-BD8B-344E5149B516Q34481647-05B8EC08-4F98-4D0A-8584-DB5ACDBA1848Q34544679-D943AEA2-D899-4EC5-BDB4-09F4E7957E99Q34741388-5EB93500-AB1A-43AD-AC8D-EDBFF674ADDDQ35194598-5141A9DC-68C6-4B40-849D-AA74C9667C6FQ35622016-B1436C86-9B0A-4BCE-BD20-4D025FEEB28DQ35622021-A0A1190B-8370-4620-8964-455C143D4540Q35668229-8BBA470B-0117-4D62-9D10-A7F958F0D68DQ35681254-AAC2FDD9-016E-4775-A5A4-C876C15CAFFEQ36094939-9CDAB6B7-6909-495B-A56F-5F00398C0874Q36163345-994C6BC0-B432-4AD0-8D53-2CDB0ED9E732Q36233517-4D14E4A6-5F0A-4FAA-98F8-BE1468D65548Q36511881-E410204A-A703-447D-9B7F-82844E423BE9Q36521993-8A05EE5A-F27E-4638-87DC-930D70F101BDQ36615287-08F3F548-AAC3-4FE3-9FF7-3F1F8BFF88E9Q36672181-F855B4AC-A68B-48B7-B204-4972CF49CE9EQ36738130-2200A085-C3CE-4DE6-B975-6EFF2735AC2D
P2860
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
In-vitro activity of voriconaz ...... in B against filamentous fungi
@ast
In-vitro activity of voriconaz ...... in B against filamentous fungi
@en
In-vitro activity of voriconaz ...... in B against filamentous fungi
@nl
type
label
In-vitro activity of voriconaz ...... in B against filamentous fungi
@ast
In-vitro activity of voriconaz ...... in B against filamentous fungi
@en
In-vitro activity of voriconaz ...... in B against filamentous fungi
@nl
prefLabel
In-vitro activity of voriconaz ...... in B against filamentous fungi
@ast
In-vitro activity of voriconaz ...... in B against filamentous fungi
@en
In-vitro activity of voriconaz ...... in B against filamentous fungi
@nl
P2093
P356
P1476
In-vitro activity of voriconaz ...... in B against filamentous fungi
@en
P2093
D W Warnock
E M Johnson
P356
10.1093/JAC/42.6.741
P407
P577
1998-12-01T00:00:00Z